Eco R1 Capital, LLC Acadia Pharmaceuticals Inc Transaction History

Eco R1 Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $67.9 Million - $85.6 Million	-4,645,004 Reduced 77.53%	1,346,475 $21.9 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $61.4 Million - $80.6 Million	2,930,886 Added 95.76%	5,991,479 $145 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $51.4 Million - $82.9 Million	3,060,593 New	3,060,593 $71.4 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $4.93 Million - $7.72 Million	-135,413 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $7.4 Million - $9.94 Million	-188,476 Reduced 58.19%	135,413 $6.56 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $5.57 Million - $8.25 Million	-176,111 Reduced 35.22%	323,889 $13.7 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $18.1 Million - $25.7 Million	500,000 New	500,000 $21.4 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.